DNA earnings

Catalyst

DNA earnings

DNA earnings — 2026-08-05

Reported the quarter ending 2026-06-30: revenue $20M, net income -$47M (SEC filing). Across the print the stock moved -9.3% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

Sources

  • Financials: edgar
  • Price reaction: ohlc
8 events
DateTypeEvent
Aug 8 ScanBiotech Scan Jul 31 ScanBiotech Scan Jul 28 ScanBiotech Scan Aug 14 ScanBiotech Scan Jul 25 ScanBiotech Scan Aug 19 ScanWashout Turn Scan Aug 22 ScanBiotech Scan Jul 17 ScanBiotech Scan

No direct external sources are attached to this read.